These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

129 related items for PubMed ID: 9871745

  • 1. Quinolines as potent 5-lipoxygenase inhibitors: synthesis and biological profile of L-746,530.
    Dubé D, Blouin M, Brideau C, Chan CC, Desmarais S, Ethier D, Falgueyret JP, Friesen RW, Girard M, Girard Y, Guay J, Riendeau D, Tagari P, Young RN.
    Bioorg Med Chem Lett; 1998 May 19; 8(10):1255-60. PubMed ID: 9871745
    [Abstract] [Full Text] [Related]

  • 2. Characterization of A-93178, an iminoxy-quinoline inhibitor of leukotriene biosynthesis.
    Bell RL, Harris RR, Bouska JB, Hulkower KI, Moore J, Bhatia P, Malo PE, Kalosa T, Brooks CD, Carter GW.
    Adv Exp Med Biol; 1997 May 19; 433():91-4. PubMed ID: 9561111
    [No Abstract] [Full Text] [Related]

  • 3. Synthesis of indolylalkoxyiminoalkylcarboxylates as leukotriene biosynthesis inhibitors.
    Kolasa T, Bhatia P, Brooks CD, Hulkower KI, Bouska JB, Harris RR, Bell RL.
    Bioorg Med Chem; 1997 Mar 19; 5(3):507-14. PubMed ID: 9113329
    [Abstract] [Full Text] [Related]

  • 4. [Pyrrolo(2,3-c)quinolines and pyrrolo(3,4-d)quinolines--synthesis and investigation of lipoxygenase inhibition].
    Görlitzer K, Fabian J, Frohberg P, Drutkowski G.
    Pharmazie; 2002 Apr 19; 57(4):243-9. PubMed ID: 11998442
    [Abstract] [Full Text] [Related]

  • 5. Dioxabicyclooctanyl naphthalenenitriles as nonredox 5-lipoxygenase inhibitors: structure-activity relationship study directed toward the improvement of metabolic stability.
    Delorme D, Ducharme Y, Brideau C, Chan CC, Chauret N, Desmarais S, Dubé D, Falgueyret JP, Fortin R, Guay J, Hamel P, Jones TR, Lépine C, Li C, McAuliffe M, McFarlane CS, Nicoll-Griffith DA, Riendeau D, Yergey JA, Girard Y.
    J Med Chem; 1996 Sep 27; 39(20):3951-70. PubMed ID: 8831761
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Naphthalenic lignan lactones as selective, nonredox 5-lipoxygenase inhibitors. Synthesis and biological activity of (methoxyalkyl)thiazole and methoxytetrahydropyran hybrids.
    Ducharme Y, Brideau C, Dubé D, Chan CC, Falgueyret JP, Gillard JW, Guay J, Hutchinson JH, McFarlane CS, Riendeau D.
    J Med Chem; 1994 Feb 18; 37(4):512-8. PubMed ID: 8120869
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Synthesis and anti-inflammatory activity of chalcone derivatives.
    Herencia F, Ferrándiz ML, Ubeda A, Domínguez JN, Charris JE, Lobo GM, Alcaraz MJ.
    Bioorg Med Chem Lett; 1998 May 19; 8(10):1169-74. PubMed ID: 9871729
    [Abstract] [Full Text] [Related]

  • 11. The molecular mechanism of the inhibition by licofelone of the biosynthesis of 5-lipoxygenase products.
    Fischer L, Hornig M, Pergola C, Meindl N, Franke L, Tanrikulu Y, Dodt G, Schneider G, Steinhilber D, Werz O.
    Br J Pharmacol; 2007 Oct 19; 152(4):471-80. PubMed ID: 17704828
    [Abstract] [Full Text] [Related]

  • 12. Studies on 5-lipoxygenase inhibitors. II. Discovery, optical resolution and enantioselective synthesis of FR110302, a highly potent non-redox type 5-lipoxygenase inhibitor.
    Yatabe T, Kayakiri H, Kawai Y, Oku T, Tanaka H.
    Chem Pharm Bull (Tokyo); 1998 Oct 19; 46(10):1556-65. PubMed ID: 9810693
    [Abstract] [Full Text] [Related]

  • 13. Lipoxygenase inhibitors, Part 6. Synthesis of new tetrahydropyrazine and other heterocyclic compounds by reaction of hydrazonoyl chlorides.
    Frohberg P, Wiese M, Nuhn P.
    Arch Pharm (Weinheim); 1997 Mar 19; 330(3):47-52. PubMed ID: 9167446
    [Abstract] [Full Text] [Related]

  • 14. Quinoline-based imidazole-fused heterocycles as new inhibitors of 15-lipoxygenase.
    Dianat S, Moghimi S, Mahdavi M, Nadri H, Moradi A, Firoozpour L, Emami S, Mouradzadegun A, Shafiee A, Foroumadi A.
    J Enzyme Inhib Med Chem; 2016 Mar 19; 31(sup3):205-209. PubMed ID: 27424740
    [Abstract] [Full Text] [Related]

  • 15. Benzothiazole hydroxy ureas as inhibitors of 5-lipoxygenase: use of the hydroxyurea moiety as a replacement for hydroxamic acid.
    Greco MN, Hageman WE, Powell ET, Tighe JJ, Persico FJ.
    J Med Chem; 1992 Aug 21; 35(17):3180-3. PubMed ID: 1324317
    [Abstract] [Full Text] [Related]

  • 16. Phosphorylation- and stimulus-dependent inhibition of cellular 5-lipoxygenase activity by nonredox-type inhibitors.
    Fischer L, Szellas D, Rådmark O, Steinhilber D, Werz O.
    FASEB J; 2003 May 21; 17(8):949-51. PubMed ID: 12670876
    [Abstract] [Full Text] [Related]

  • 17. Substituted thiopyrano[2,3,4-c,d]indoles as potent, selective, and orally active inhibitors of 5-lipoxygenase. Synthesis and biological evaluation of L-691,816.
    Hutchinson JH, Riendeau D, Brideau C, Chan C, Delorme D, Denis D, Falgueyret JP, Fortin R, Guay J, Hamel P.
    J Med Chem; 1993 Sep 17; 36(19):2771-87. PubMed ID: 8410991
    [Abstract] [Full Text] [Related]

  • 18. A new class of leukotriene biosynthesis inhibitor: the development of MK-0591.
    Prasit P, Belley M, Blouin M, Brideau C, Chan C, Charleson S, Evans JF, Frenette R, Gauthier JY, Guay J.
    J Lipid Mediat; 1993 Sep 17; 6(1-3):239-44. PubMed ID: 8357985
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. CarbORev-5901: The First Carborane-Based Inhibitor of the 5-Lipoxygenase Pathway.
    Kuhnert R, Sárosi MB, George S, Lönnecke P, Hofmann B, Steinhilber D, Murganic B, Mijatovic S, Maksimovic-Ivanic D, Hey-Hawkins E.
    ChemMedChem; 2017 Jul 06; 12(13):1081-1086. PubMed ID: 28569429
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.